Neurogene (NGNE) Free Cash Flow (2013 - 2026)
Neurogene (NGNE) posted Free Cash Flow of -$26.4 million for Q1 2026, down 59.94% on a QoQ basis from -$16.5 million in Q4 2025, and down 22.39% year-over-year from -$34.0 million in Q1 2025.
Neurogene (NGNE) Free Cash Flow (2013 - 2026) Analysis & Trends
Neurogene's Free Cash Flow history runs 14 years deep, the most recent figure standing at -$26.4 million for Q1 2026.
- Quarterly Free Cash Flow fell 22.39% year-over-year to -$26.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$82.1 million (down 15.45% YoY) and the FY2025 annual result came in at -$77.2 million, down 8.3% from the prior year.
- Free Cash Flow was -$26.4 million for Q1 2026 at Neurogene, down from -$16.5 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$9.4 million in Q2 2023 and bottomed at -$26.4 million in Q1 2026.
- A 5-year average of -$16.6 million and a median of -$16.5 million in 2025 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2023 — Free Cash Flow grew 20.69% — and 2024, when it sank 72.66%.
- Neurogene's Free Cash Flow stood at -$19.3 million in 2022, then advanced by 11.63% to -$17.1 million in 2023, then fell by 2.45% to -$17.5 million in 2024, then gained by 5.85% to -$16.5 million in 2025, then slumped by 59.94% to -$26.4 million in 2026.
- Business Quant data shows NGNE's Free Cash Flow at -$26.4 million in Q1 2026, -$16.5 million in Q4 2025, and -$19.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.49 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 158.09 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -354.95 Mn |
| 10 | Neurogene | 776.69 Mn | 776.69 Mn | - | -26.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.38 Mn |
| Mar 31, 2026 | -26.38 Mn |
| Dec 31, 2025 | -16.49 Mn |
| Dec 31, 2025 | -16.49 Mn |
| Sep 30, 2025 | -19.63 Mn |
| Sep 30, 2025 | -19.63 Mn |
| Jun 30, 2025 | -19.57 Mn |
| Jun 30, 2025 | -19.57 Mn |
| Mar 31, 2025 | -21.55 Mn |
| Mar 31, 2025 | -21.55 Mn |
| Dec 31, 2024 | -17.52 Mn |
| Dec 31, 2024 | -17.52 Mn |
| Sep 30, 2024 | -15.74 Mn |
| Sep 30, 2024 | -15.74 Mn |
| Jun 30, 2024 | -16.28 Mn |
| Jun 30, 2024 | -16.28 Mn |
| Mar 31, 2024 | -21.79 Mn |
| Mar 31, 2024 | -21.79 Mn |
| Dec 31, 2023 | -17.10 Mn |
| Dec 31, 2023 | -17.10 Mn |